Search results
Daniel Louis Doctoroff (born July 11, 1958 [1]) is an American businessman and former government official. [2] From 2015 to 2021, he served as Chief Executive Officer of Sidewalk Labs, a startup company he helped found focused on technology for city life.
Having lost both his father and uncle to ALS, Daniel L. Doctoroff founded Target ALS, a transformative biomedical research nonprofit, in 2013 to accelerate discovery of effective treatments for ALS. In October 2021, Dan himself was diagnosed with ALS.
Told through the eyes of the individuals who worked with Doctoroff to lead these projects and accompanied by more than 450 photos, The Urbanist tells the astonishing story of the role that one man played in recreating New York City during one of its most transformative eras.
DANIEL L. DOCTOROFF. Having lost both his father and uncle to ALS, Daniel L. Doctoroff founded Target ALS in 2013 in collaboration with Bloomberg Philanthropies and financier and philanthropist David Rubenstein to create a new collaborative framework for scientists.
Daniel L. Doctoroff stepped down as Chairman and CEO of Sidewalk Labs, Alphabet’s pioneering urban innovation company, in late 2021 upon being diagnosed with ALS.
Doctoroff and his team created a new collaborative model of research that has been a major catalyst to understanding the genetics and biology of ALS and has lowered the barriers to entry for new scientific discovery, and has helped to induce over 100 biotech, pharmaceutical, and venture capital firms to demonstrate interest in the disease.
Daniel Doctoroff is the former President and Chief Executive Officer of Bloomberg LP, the leading provider of financial information. He joined Bloomberg in January 2008 as President of the company and was appointed Chief Executive Officer in August 2011.
